Edgestream Partners, L.P. Gilead Sciences, Inc. Transaction History

Edgestream Partners, L.P.

$2.05 Billion
Q2 2024

A detailed history of Edgestream Partners, L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 12,299 shares of GILD stock, worth $1.08 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

12,299

Previous 52,973 76.78%

Holding current value

$1.08 Million

Previous $3.88 Million 78.27%

% of portfolio

0.04%

Previous 0.2%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $2.57 Million - $2.96 Million	-40,674 Reduced 76.78%	12,299 $843,000
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $3.1 Million - $3.78 Million	43,300 Added 447.64%	52,973 $3.88 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $347,373 - $393,929	-4,741 Reduced 32.89%	9,673 $783,000
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $848,239 - $925,446	11,472 Added 389.94%	14,414 $1.08 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $836,338 - $953,960	-11,003 Reduced 78.9%	2,942 $226,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $489,913 - $558,162	6,337 Added 83.29%	13,945 $1.16 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $840,073 - $1.21 Million	-13,480 Reduced 63.92%	7,608 $653,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.26 Million - $1.43 Million	21,088 New	21,088 $1.3 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $463,070 - $580,277	-7,995 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $109,971 - $124,819	-1,695 Reduced 17.49%	7,995 $581,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $655,916 - $707,660	9,690 New	9,690 $677,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $4.69 Million - $5.34 Million	-82,753 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $5.14 Million - $6.46 Million	82,753 New	82,753 $5.23 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $1.1 Million - $1.41 Million	-17,595 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $816,773 - $898,423	13,255 Added 305.41%	17,595 $1.14 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $271,293 - $299,460	4,340 New	4,340 $275,000
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $385,573 - $432,376	-6,232 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $389,686 - $436,551	6,232 New	6,232 $405,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Gilead Sciences, Inc. Transaction History